CDSCO monthly lab alert
CDSCO NSQ alert, May 2025: 188 drug batches flagged
By Blacklisted editorial team· Published 20 Jun 2025· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its May 2025 alert, the Central Drugs Standard Control Organisation listed 188 drug batches that failed quality tests, 58 at central laboratories and 130 at state drug-testing laboratories, from 147 manufacturers across 141 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Pantoprazole for Injection BP 40 mg, Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500), White Powder Paracetamol IP.
188
Batches flagged
58 / 130
Central / state labs
Assay
Top reason
147
Manufacturers
Batches per month, last 12 alerts
Jun 2024May 2025 · 188
Full list of NSQ batches, May 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Tablets I.P. 20 mg (TONZEE 20) | Batch ZS-2404Mfg May 2024 · Exp Apr 2026 | Torino Laboratories Pvt. LtdMadhya Pradesh | The Sample does not conform to Standard Quality in respect of the test for DisintegrationDisintegration | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch LMT240804Mfg Jul 2024 · Exp Jun 2026 | Life Max Cancer Laboratories | Uniformity of Dispersion & DisintegrationDisintegration | RDTL, GuwahatiCDSCO lab |
| Zaflox-OZ Tablet | Batch TLT-6938Mfg Feb 2024 · Exp Jan 2026 | Taksa Lifescience E-47Chandigarh | 1.The sample fails in the Dissolution Test of Ofloxacin IP & Ornidazole IP 2.The sample does not conform to the Assay content of Ofloxacin IP 3.The sample is also found Misbranded as Ofloxacin and Ornidazole Tablets are not been shown official as per I.P 2022Assay | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| White Powder Paracetamol IP | Batch PAR040325Mfg Mar 2025 · Exp Feb 2030 | Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195 | Identification Test Found To be Negative. Assay of Paracetamol IP-NILAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| White Powder Paracetamol IP | Batch PAR050325Mfg Mar 2025 · Exp Feb 2030 | Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195 | Identification Test Found To be Negative. Assay of Paracetamol IP-NILAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| Vitamin B-Complex with Vitamin C and Biotin Capsules (Vitabon) | Batch C-3465Mfg Nov 2024 · Exp Oct 2026 | Jackson Laboratories Pvt. LtdPunjab | Assay/content of Calcium PantothenateAssay | CDL, KolkataCDSCO lab |
| Vitamin B Complex Injection 30 ml (WA-PLEX) | Batch 111Mfg Dec 2024 · Exp May 2026 | Weismanna Health Care Pvt. LtdAndhra Pradesh | Description and Particulate matterDescription | CDL, KolkataCDSCO lab |
| Ursodeoxycholic acid Tablets IP 300 mg | Batch UDS-501Mfg Aug 2024 · Exp Jul 2026 | Healers Lab Unit IIHimachal Pradesh | The sample does not confirm to claim as per IP 2022 in respect to the Dissolution of Ursodiol (Ursodeoxycholic Acid)Dissolution | DTL Baddi Distt. SolanState lab |
| Trypsin, Bromelain, Rutoside, Trihydrate & Diclofenac Tablets (RUMIHEAL-D) | Batch SRTF240703BMfg Jun 2024 · Exp ? | Systole Remedies Pvt. LtdHimachal Pradesh | Test for DisintegrationDisintegration | DTL Baddi Distt Solan HPState lab |
| Trenbolone Enanthate Injection 200mg/ml (FINAREX 200) | Batch TST2301Mfg ? · Exp Apr 2027 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Trenbolone Acetate Injection 100mg/ml... (FINEXAL 100) | Batch TST2301Mfg ? · Exp Apr 2027 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Tranexamic Acid Tablets IP (Trenaxa 500) | Batch 18242021AMfg Aug 2024 · Exp Jul 2027 | Macleods Pharmaceuticals LtdSikkim | Spurious Identification and Assay of Tranexamic AcidAssay | CDL, KolkataCDSCO lab |
| Testosterone Propionate 100mg/ml (P-JECT) | Batch INLDAN1801Mfg Feb 2024 · Exp Jan 2028 | Novector Labs | Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Telmisartan Tablets IP 40mg (Telma 40) | Batch K18230707Mfg Jun 2024 · Exp May 2027 | Under Investigation | Identification and Assay of TelmisartanAssay | CDL, KolkataState lab |
| Telmisartan Tablets IP 40mg | Batch 251TTF025Mfg Dec 2024 · Exp Nov 2027 | Swiss Garnier Life SciencesHimachal Pradesh | DissolutionDissolution | RDTL, GuwahatiCDSCO lab |
| Telmisartan Tablets IP 40 mg | Batch 251TTF036Mfg Dec 2024 · Exp Nov 2026 | Swiss Garnier Life SciencesHimachal Pradesh | DissolutionDissolution | RDTL, GuwahatiCDSCO lab |
| Telmisartan Tablets I.P. 40mg (Telma 40) | Batch 5240226Mfg Feb 2024 · Exp Jan 2027 | Under Investigation | DissolutionDissolution | CDL, KolkataState lab |
| Telmisartan Tablets I.P. 20 mg (TELSAT ? 20) | Batch ST2T2302Mfg Mar 2024 · Exp Feb 2026 | Goodman Pharmaceuticals | The Sample does not conform to standard in respect of the test for Dissolution performedDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Telmisartan & Amlodipine TabletsIP (Lanztel-AM) | Batch RHT24-402Mfg Jul 2024 · Exp Jun 2026 | Revantis HealthcareHimachal Pradesh | Does not comply with respect to test for AssayAssay | State lab , PuducherryState lab |
| Tamsulosin Hydrochloride & Dutasteride tab (Urimax-D | Batch 4GH0097Mfg Dec 2023 · Exp Nov 2025 | Cipla LtdGoa | Negative for the presence of Tamsulosin Hydrochloride & DutasterideOther | State Drug Control & Research Lab, West BengalState lab |
| Super Bulk-Mix Rx Only (Super Bulk-Mix Rx) | Batch CQ20215MIOSMfg Feb 2024 · Exp Jan 2027 | Not applicable | Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Sulphamethoxazole &Trimethoprim Injection I.P. | Batch EL-240608Mfg Jun 2024 · Exp May 2026 | Ethicare LaboratoriesJammu & Kashmir | The sample does not conform to the IP (Vet.) with respect to Particulate Matter, Description as it show physical in stability in the form of white crystalline particles and Assay of TrimethoprimAssay | DTL,Jaipur(State Lab)State lab |
| Sulcralfate& Oxetacaine Suspension(Piracid-O Suspension) | Batch R05GL2423AMfg May 2024 · Exp Apr 2026 | Rednex Pharmaceuticals Pvt. LtdKerala | Assay for Oxetacaine OnlyAssay | KarnatakaState lab |
| Sucralfate Oral Suspension (AXID 200) | Batch 624-470Mfg Jun 2024 · Exp May 2026 | Zee Laboratories Ltd | The sample does not conform to claim standards with respect to descriptionDescription | CDTL- ChennaiCDSCO lab |
| Sterile Diluent For Reconstitution of ND, IB, IBD and Combination Vaccines for Poultry (Veterinary) Multi | Batch GSCEV03Mfg Nov 2023 · Exp Oct 2025 | Safe Parenterals Pvt.LtdAndhra Pradesh | Description & Particulate MatterDescription | KarnatakaState lab |
| Stanozolol Injection 100mg/ml (VENAJECT) | Batch TST2301Mfg ? · Exp Apr 2027 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Spnflox-OZ Tablets (Ofloxacin &OrnidazoleTablets IP) | Batch DT240523BMfg May 2024 · Exp Apr 2026 | Indo Rama Health Care Pvt.Ltd | Description of TabletsDescription | KarnatakaState lab |
| Sodium Valporate IP Powder | Batch SV/02/01/25Mfg Jan 2025 · Exp Dec 2029 | Mirambika Pigment | Loss on drying: Does not comply with IP, Assay of Sodium Valporate IP: More than Prescribed LimitAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| Sodium Chloride InjectionIP0.9% w/v (NS) | Batch UA404B026Mfg Jan 2025 · Exp Dec 2027 | Puniska lnjectables Pvt.LtdGoa | Test for SterilitySterility | KarnatakaState lab |
| Sodium Chloride Injection U.S.P.(3% w/v) (Hypertonic 3NS 100 ml) | Batch G250146001Mfg Jan 2025 · Exp Dec 2027 | Vision Parental Pvt. Ltd | Particulate MatterParticulate matter | CDL, KolkataCDSCO lab |
| Sodium Chloride Injection IP 0.9% w/v (NS) | Batch TL304F003Mfg Nov 2024 · Exp Oct 2027 | Puniska lnjectables Pvt.LtdGoa | Test for SterilitySterility | KarnatakaState lab |
| Sodium Chloride Injection I.P. (0.9% w/v).. (NS) | Batch 01BF2354Mfg Mar 2024 · Exp Feb 2027 | Paschim Banga Pharmaceuticals | Sterillity & DescriptionDescription | RDTL, GuwahatiCDSCO lab |
| Sitagliptin & Metformin Tablets 50 mg + 1000 mg (Sitajack-M) | Batch T-2916Mfg Sep 2024 · Exp Aug 2026 | Jackson Laboratories Pvt. LtdPunjab | Assay of SitagliptinAssay | CDL, KolkataCDSCO lab |
| Sildenafil citrate oral jelly 5 gm (King of jelly) | Batch 25005Mfg Feb 2025 · Exp Jan 2028 | Banson Pharmaceutical Pvt. Ltd | Description and Assay of Sildenafil CitrateAssay | RDTL, ChandigarhCDSCO lab |
| SPORLAC Tablets (Tablets of Probiotics) | Batch MS024004Mfg Apr 2024 · Exp May 2026 | J.B. Chemicals & Pharmaceuticals LtdUttarakhand | Identification of Bacillus clausiiIdentification | CDTL-MumbaiCDSCO lab |
| Robiflam-SP | Batch UTGRFB401Mfg May 2024 · Exp Apr 2026 | Khandelwal Laboratories Pvt. LtdUttarakhand | The sample fails in the test for Description of tabletsDescription | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Ranitidine Injection IP-2ML | Batch HLI352CMfg Mar 2024 · Exp Feb 2026 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to requirement for AssayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Ranitidine Hydrochloride Tablets IP 150mg (Zeptiloc-150 tablets) | Batch ZCI24003Mfg Apr 2024 · Exp Mar 2026 | Danish Healthcare (P) Ltd. 76/27-28 | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Rabeprazole Sodium Injection IP 20 mg/vial | Batch MD23H27Mfg Aug 2023 · Exp Jul 2025 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | pH, Clarity of Solution, Particulate matter, Uniformity of Weight, Assay of Rabeprazole Sodium and Description.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Gastro- resistant & Domperidone (SR) Capsules (Rebtil-DSR) | Batch LV23LC-017Mfg Nov 2023 · Exp Oct 2025 | L.V. Life SciencesHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL,Bikaner (State Lab)State lab |
| Rabeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules (Kylid-RD) | Batch NHD24207CMfg May 2024 · Exp Apr 2026 | Nest Healthcare Pvt.LtdGujarat | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL, Jaipur (State Lab)State lab |
| Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Releases) Capsules (Rzol-D) | Batch SSC23187Mfg Jan 2024 · Exp Dec 2025 | Shri Sai Bala Ji Pharmatech Pvt.LtdHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Rabeprazole SodiumAssay | DTL,Bikaner (State Lab)State lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (Dorsai) | Batch DYC-24007Mfg Apr 2024 · Exp Mar 2026 | DYCOTT HealthcareHimachal Pradesh | Dissolution of Rabeprazole Sodium (acid stage), Dissolution of Rabeprazole Sodium (buffer stage) and Assay of Rabeprazole SodiumAssay | CDL, KolkataCDSCO lab |
| Povidone Iodine Gargle 2% (ZEVODINE) | Batch 623-864Mfg Nov 2023 · Exp Oct 2025 | Zee Laboratories LtdHimachal Pradesh | Test For Assay (Content) of Povidone-Iodine Equivalent To Available-IodineAssay | Government of NCT of DelhiState lab |
| Pomol-650 (Paracetamol Tablets I.P. 650mg) | Batch 24020111Mfg Feb 2024 · Exp Jan 2027 | Mls.Aban PharmaceuticalsKerala | Test for Dissolution of Tablets and content of Paracetamol in the AssayAssay | KarnatakaState lab |
| Phenytoin Sodium Injection USP-2ml | Batch 45PSA138Mfg May 2024 · Exp Apr 2026 | SPM Drugs (P) Ltd | Sample does not conform to the requirement for assayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Park 650 | Batch AT24/391Mfg Aug 2024 · Exp Jul 2026 | Accuwell Medics Pvt LtdGujarat | The sample fails in the test for Uniformity of Weight of Tablets & Assay content of ParacetamolAssay | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Paracetamol Tablets IP 650mg | Batch PCT24034Mfg Feb 2024 · Exp Jan 2026 | Vivek Pharmachem (India) LtdRajasthan | The sample has been declared as not of Standard Quality as it does not conform to IP standards with respect to Test for Dissolution and DescriptionDissolution | �KarnatakaState lab |
| Paracetamol Tablets I.P 500mg(Fevimed) | Batch 451AA05Mfg Dec 2023 · Exp Nov 2025 | Sarv PharmaceuticalsUttarakhand | The sample does not comply for Description as, the tablets shows uneven light Brown Coloured Spots on the Surface of almost all the Tablets.Description | N.S. Bhalerao, Hingoli , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Paracetamol Tablet I.P 500 mg | Batch KA1334Mfg Dec 2023 · Exp Nov 2026 | Karnataka Antibiotics & Pharmaceuticals LtdKarnataka | DescriptionDescription | CDTL- IndoreCDSCO lab |
| Paracetamol 250 mg & Mefenamic Acid 100 mg Suspension, 60 ml (Pacimol MF 250 Suspension) | Batch INC014022RMfg Apr 2024 · Exp Mar 2026 | Ipca Laboratories Ltd | Assay of Paracetamol and Mefenamic AcidAssay | CDTL-MumbaiCDSCO lab |
| Pantoprazole for Injection BP 40 mg | Batch AA013026Mfg Jun 2023 · Exp May 2025 | ANG Lifesciences India LtdHimachal Pradesh | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab |
| Pantoprazole for Injection BP 40 mg | Batch AA013043Mfg Aug 2023 · Exp Jul 2025 | ANG Lifesciences India LtdHimachal Pradesh | Clarity and colour of solutionDescription | CDL, KolkataCDSCO lab |
| Pantoprazole for Injection BP 40 mg | Batch AA013047Mfg Sep 2023 · Exp Aug 2025 | ANG Lifesciences India LtdHimachal Pradesh | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab |
| Pantoprazole Tablets IP 40 mg | Batch 92Mfg Jul 2024 · Exp Jun 2026 | Hindustan Antibiotics LtdMaharashtra | Dissolution and DescriptionDissolution | CDL, KolkataCDSCO lab |
| Pantoprazole Gastro-Resistant Tablets IP 40 mg, | Batch 431Mfg Nov 2024 · Exp Apr 2026 | Stride Organics Private LtdTelangana | The drug failed to indicate the common name of the color contained in the drug on the label of the product, as required by Rule 127(2) of the Drugs Rules, 1945. It was mentioned on the label as Approved Colours UsedLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Pantoprazole Gastro resistant &Domperidone prolonged release Capsules IP | Batch PZD242206Mfg Jan 2025 · Exp Dec 2026 | Paradox PharmaceuticalsHimachal Pradesh | Identification and Assay of Pantoprazole Sodium calculated as Pantoprazole and Domperidone and the Dissolution of Pantoprazole Sodium calculated as Pantoprazle.Assay | RDTL, ChandigarhCDSCO lab |
| Pantoprazole Gastro-resistant & Domperidone Prolonged Release Capsuels IP (Pantocoat- DAR) | Batch C112403Mfg Nov 2024 · Exp Oct 2026 | Mls.Swefn Pharmaceuticals Pvt.LtdGujarat | Description of TabletsDescription | KarnatakaState lab |
| Ondansetron Injection IP 2 mg/ml | Batch ONA12515Mfg Jan 2025 · Exp Dec 2026 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | Particulate matterParticulate matter | CDL, KolkataCDSCO lab |
| Ondansertron Orally Disintegrating Tablets IP 4 mg (ONVIN-4 MD TABLETS) | Batch RV24012Mfg May 2024 · Exp Apr 2026 | Rivpra Formulation Pvt. LtdUttarakhand | Related SubstancesRelated substances | CDL, KolkataCDSCO lab |
| Om Shanthi Gold Class KUMKUM, | Batch BL0lMfg Dec 2024 · Exp Nov 2025 | N. Rangarao & Sons Pvt.Ltd | Test for Fineness residue onlyOther | KarnatakaState lab |
| Olanzapine Tablets I.P.5mg. (Olanzapine Tablets IP 5mg) | Batch N2503121Mfg Mar 2025 · Exp Feb 2028 | Talent HealthcareUttarakhand | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Olanzapine Tablet I.P. (Etimok) | Batch ATD-B24020Mfg Feb 2024 · Exp Jan 2026 | Alzan Pharmaceuticals Pvt | Uniformity of contentUniformity of weight/content | State Drugs Laboratory, PunjabState lab |
| Ofloxacin and Ornidazole Tablets IP 200 mg+500mg | Batch DL-136Mfg Dec 2024 · Exp Nov 2026 | DUTCH FormulationsHimachal Pradesh | Uniformity of weight, Dissolution of Ornidazole, Dissolution of Ofloxacin and Assay of Ofloxacin and OrnidazoleAssay | RDTL, ChandigarhCDSCO lab |
| Ofloxacin Tablets IP 200 mg | Batch DL-55Mfg Oct 2024 · Exp Sep 2026 | DUTCH FormulationsHimachal Pradesh | Dissolution and Assay of OfloxacinAssay | RDTL, ChandigarhCDSCO lab |
| Norfloxacin Tablets I.P.400mg, | Batch 4Mfg Feb 2025 · Exp Jul 2026 | Stride Organics Private LtdTelangana | The sample does not comply with respect to Dissolution Test as per IPDissolution | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Norfloxacin Tablets I.P. 400mg (Norfloxacin 400) | Batch R-240327Mfg Mar 2024 · Exp Feb 2026 | Remax Pharmaceuticals | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Nifedipine Sustained Release Tablets IP 10 mg | Batch NF24007Mfg Aug 2024 · Exp Jan 2026 | Eurokem Laboratories Pvt ltd | Sample does not conform to IP specification for Nifedipine Sustained Release Tablets with respect to the content of NifedipineOther | Drugs Testing Laboratory, Madurai-19State lab |
| Neo-Chloranton | Batch T-3750Mfg Dec 2023 · Exp Nov 2025 | New Gayzel Pharmaceuticals 6/4 Modern Industrial Estate Bahadurgarh - 124507 Mrk. By : Remedies Pharmaceuticals (India) Pvt Ltd 107A &B Aradhana Bhawan Azadpur Commercial ComplexDelhi | The sample fails in the test for Description & Disintegration test of tabletsDescription | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Nandrolone Blend Injection 350mg/ml (DEXADUR) | Batch TST2301Mfg ? · Exp Apr 2027 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Moxi-KT EYE DROPS (Moxifloxacin 0.5 % + Ketorolac 0.4% + H.P.M.C. 0.025 % Opthalmic solution) | Batch 3780Mfg Aug 2024 · Exp Jul 2026 | Eden Drugs Pvt. Ltd. S.G.R.D.J. Airport Road Meerankot Distt. AmritsarPunjab | Assay of Ketorolac(80.75%)Assay | DTL Baddi Distt Solan HPState lab |
| Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP (BLUCAST-L) | Batch ZP24T176Mfg Aug 2024 · Exp Jul 2026 | Zantic Pharmaceuticals Pvt. Ltd. (AGMP Certified Unit) G-86Uttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Dissolution of Montelukast & Levocetirizine HydrochlorideDissolution | DTL BaddiState lab |
| Misoprostol Tablets IP 200 mcg(Misotop 200) | Batch SPT241229Mfg Jun 2024 · Exp May 2026 | Salus Pharmaceuticals 480/211Himachal Pradesh | The content of Misoprostol in the sample is less (i.e 13.82% of the lablled amount) than the IP limitsOther | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Metronidazole Tablets IP 400 mg | Batch B240578Mfg May 2024 · Exp Apr 2027 | Bochem Healthcare Pvt. Ltd | DissolutionDissolution | RDTL, ChandigarhCDSCO lab |
| Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Folic Acid, Inositol & Niacinamide Softgel Capsules (S-Neuro Plus) | Batch SD240762Mfg Apr 2024 · Exp Sep 2025 | Bajaj NutraceuticalsUttarakhand | (1) For the received sample Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Folic Acid, Inositol & Niacinamide Softgel Capsules (S-NEURO PLUS), Leakage of the soft gelatin capsules was observed which should not be present as per rule 124B of the Drugs Rules,1945 (2) Does not comply with respect to test for DesintegrationOther | State lab , PuducherryState lab |
| Mefenamic Acid and Paracetamol Suspension (Sarmef-PDS) | Batch SBL-1021Mfg Oct 2024 · Exp Sep 2026 | Sarthak Biotech Pvt. Ltd | VolumeOther | State Drugs Laboratory, PunjabState lab |
| Maxirest ?LP Tablets | Batch MPT23365Mfg Mar 2024 · Exp Feb 2026 | Micro Organics Pharmaceuticals (India)Pvt LtdChandigarh | The sample fails in the test for Description of tabletsDescription | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Manoril-BR Syrup (Terbutaline Sulphate, Bromhexine HCL, Guaiphenesin and Menthol Syrup) | Batch ASL24199Mfg Oct 2024 · Exp Sep 2026 | AASSK Pharmaceuticals Pvt. LtdTamil Nadu | Sample does not conform to Label claim with respect to the content of Bromhexine HydrochlorideLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| MULTIPLE ELECTROLYTES AND DEXTROSE INJ. TYPE-1 I.P. (AROLYTE P) | Batch 1227421SMfg Dec 2024 · Exp Nov 2027 | Shree KrishnaKeshav Laboratories LtdGujarat | Assay of PotassiumAssay | CDTL-MumbaiCDSCO lab |
| MITO Q7 Syrup (Co Enzyme Q10, L- Carnitine, Benfotiamine, Riboflavin, Pyridoxine HCL | Batch CHS-40170Mfg Sep 2024 · Exp Feb 2026 | Bion Therapeutics India Pvt.LtdUttarakhand | Assay for Benfotiamine, Riboflavinand,AscorbicAcidAssay | KarnatakaState lab |
| METRONIDAZOLE TABLETS IP (Martigyl-400) | Batch MT-24D03Mfg Apr 2024 · Exp Mar 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | DissolutionDissolution | RDTL, GuwahatiCDSCO lab |
| Lomojack | Batch CN2305Mfg Apr 2023 · Exp Sep 2025 | Century Drugs Pvt. LtdMadhya Pradesh | The sample does not comply with I.P requirement for Dissolution Test"Dissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| KAAMRAJ (Suspected to contain Sildenafil and Tadalafil (Brahmanands) | Batch BAC0003Mfg Jan 2023 · Exp Dec 2025 | Brahmanand Ayurveda (OPC) Pvt. LtdPunjab | 1) Identification Test for Sildenafil found to be Negative. 2) Identification test for Tadalafil found to be PositiveIdentification | State Drugs Laboratory, PunjabState lab |
| Itraconazole Ofloxacin, Ornidazole & Clobetasol Propionate Cream (Fondastop C Cream) | Batch 0-102Mfg Sep 2023 · Exp Aug 2025 | Spen Formulations Pvt. Ltd | The sample does not give High Performance Liquid Chromatographic and Thin Layer Chromatographic identification Test for the presence of itraconazole and Clobetasol Propionate.Identification | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Itraconazole Capsules BP 100 mg (ITR 100 | Batch 5007Mfg Jul 2023 · Exp Jun 2025 | Orley Laboratories Pvt. Ltd. 1817Gujarat | The sample does not comply with B.P requirements for Dissolution TestDissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Isoxsuprine Hydrochloride (SR)Tablets(Siox-Sr) | Batch GT400966AMfg Oct 2024 · Exp Sep 2026 | Gnosis Pharmaceuticals Pvt. Ltd. Nahan RoadHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Isoxsuprine HydrochlorideAssay | DTL,Jaipur(State Lab)State lab |
| Iron Sucrose Injection USP l00mg (Irogain) | Batch IISI406Mfg Sep 2024 · Exp Jul 2026 | U/s. Regain LaboratoriesChhattisgarh | Test for Fineness residue onlyOther | KarnatakaState lab |
| Injection Oxytocin Vet. 50 ml Vial | Batch Not applicableMfg ? · Exp ? | Not applicable | pH and SterilitySterility | RDTL, ChandigarhCDSCO lab |
| Injection Oxytocin Vet. 100 ml Vial | Batch Not applicableMfg ? · Exp ? | Not applicable | pH and SterilitySterility | RDTL, ChandigarhCDSCO lab |
| Ibuprofen Oral Suspension BP 100 mg/5ml | Batch IBS-022Mfg Jul 2024 · Exp Jun 2026 | Medipol Pharmaceuticals India Pvt. Ltd. 1199/3Himachal Pradesh | The sample does not conform to claim as per BP 2024 in respect to the Assay of IbuprofenAssay | DTL Baddi Distt. SolanState lab |
| Halar Cream | Batch HA-292Mfg Jul 2023 · Exp Jun 2026 | Maxheal Pharmaceuticals (I) Ltd. J-7 M.I.D.C Tarapur Industrial AreaMaharashtra | The content of Neomycin Sulphate (i.e. 18.80% of the labelled amount)Labelling | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Haematinic Capsules (R.B. TONE) | Batch D40652Mfg Nov 2024 · Exp Oct 2026 | Medley Pharmaceuticals LtdDaman & Diu | Microbial limit test (Total combined yeasts/molds count)Microbial limits | CDTL-MumbaiCDSCO lab |
| Gutwell Suspension, Bacillus clausii 2 billion spores/5ml | Batch PSB-B00225Mfg Jan 2025 · Exp Dec 2027 | Prosafe Biologicals LLPTelangana | Total viable count found Less than 2 billion spores/5mlOther | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Golden Drive 250gm | Batch GDM002NMfg Oct 2023 · Exp Sep 2026 | Advanced Pakiza Unani LLPMaharashtra | 1. The sample gives identification for the presence of Sildenafil Citrate 2. Found Content of Sildenafil in the sample is 8.49mg/10gmIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| GlimepirideTablets IP 2mg (Glimiz-2), | Batch T24039Mfg Apr 2024 · Exp Mar 2026 | Knm Pharma Pvt. Ltd.13Gujarat | Assay and IP standards with respect Test for DissolutionAssay | KarnatakaState lab |
| Glimepiride Tablets IP 1mg | Batch PGG24-012Mfg Aug 2024 · Exp Jul 2026 | Pondchy PharmaceuticalsPuducherry | Sample does not conform to IP specification for Glimepiride Tablets with respect to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Glibenclamide Tablets IP 5mg | Batch NHD24411AMfg Jul 2024 · Exp Jul 2025 | Nest Healthcare Pvt.LtdGujarat | Sample does not conform to IP specificaion for Glibenclamide Tablets with respec to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Gentamicin Injection IP-2ML | Batch 24BUH85Mfg Aug 2024 · Exp Jul 2026 | SVP Life SciencesUttarakhand | Sample does not conform to the requirement for pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Gentamicin Injection I.P-2ml | Batch HLI624FMfg Jun 2024 · Exp May 2025 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to the requirement for pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Gabapentin Capsules IP 300mg. (GABATEC-300) | Batch SG2412559Mfg Dec 2024 · Exp Nov 2026 | Scout Lifescience Pvt. LtdHaryana | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab |
| Gabapentin & Nortriptyline Hydrochloride Tablets (GABVONT400) | Batch HT24642Mfg Dec 2024 · Exp Nov 2026 | HBC Healthcare Pvt. LtdGujarat | The sample does not confirm to the claim with respect to Assay of NortriptylineAssay | DTL,Jaipur (State Lab)State lab |
| Fluconazole IP Powder | Batch FLZ23-2411Mfg Nov 2023 · Exp Oct 2028 | Mestra Pharma Pvt. LtdUttarakhand | Loss on drying: Does not comply with IPLoss on drying | State Food & Drug Testing Laboratory UttarakhandState lab |
| Fluconazole 150mg Tablets IP (PRATIFLU 150 Tablets | Batch PPTS-2801Mfg Aug 2024 · Exp Jul 2027 | Pratima PharmaceuticalsMaharashtra | The content of Fluconazole in the sample is less (i.e 31.96% of the stated amount) (I.P. Limits:- Not less than 90% and not more than 110% of the stated Amount)Other | V.P. Khedkar, Pune-Zone 2State lab |
| Fexofenadine Tablets IP (Fexodil 180 mg) | Batch T-4029Mfg Jan 2025 · Exp Dec 2026 | Jackson Laboratories Pvt. LtdPunjab | Dissolution test after 10 min and after 30 minDissolution | CDL, KolkataCDSCO lab |
| Ferrous Sulphate & Folic Acid Syrup IP | Batch FSF-158Mfg Oct 2024 · Exp Sep 2026 | Medipol Pharmaceuticals India Pvt. Ltd. 1199/3Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Free Ferric Compounds & Assay of Folic AcidAssay | DTL Baddi Distt. SolanState lab |
| Fenacin (Diclofenac Diethylammonium + Methyl Salicylate + Menthol Gel) | Batch DG2402Mfg Apr 2024 · Exp Mar 2026 | Johnson & Smith CoKarnataka | Sample does not conform to Label claim with respect to the content of Methyl SalicylateLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| Enzox Liquid Digestive Supplement | Batch ES-24011/11Mfg Dec 2024 · Exp May 2026 | Tidal Laboratories Pvt. Ltd. Patch-5 | Assay/Content of Pepsin activity.Assay | CDL, KolkataCDSCO lab |
| Entcof Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate Syrup) | Batch MMR-344Mfg Mar 2024 · Exp Feb 2026 | Mediguard Remedies | Sample does not conform to Label claim with respect to the content of Terbutalline SulphateLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| Doxycycline and Lactic Acid BacillusTablets(DOXYGLO-LB) | Batch ATG4G566Mfg Jul 2024 · Exp Jun 2026 | Anrose PharmaHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Doxycycline Hydrochloride IPAssay | DTL,Jaipur (State Lab)State lab |
| Dolomol 650 | Batch RBT-2042Mfg Oct 2024 · Exp Jun 2027 | Rockbrook Overseas Pvt Ltd | The sample fails in the dissolution test of paracetamolDissolution | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Dobutamine Hydrochloride Injection IP 5 ml | Batch DBA12404Mfg Aug 2024 · Exp Jul 2026 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab |
| Disposable Syringes (5ml) (SUI) | Batch 4051124S11Mfg Nov 2024 · Exp Oct 2027 | Hindustan Ultra Care LimitedRajasthan | SterillityOther | RDTL, GuwahatiCDSCO lab |
| Dicyclomine Hydrochloride Tablets IP 10 mg | Batch TK24-08Mfg Nov 2024 · Exp Oct 2026 | Om Biomedic Pvt. LtdUttarakhand | DescriptionDescription | RDTL, GuwahatiCDSCO lab |
| Dicyclomine HCL Powder | Batch DEH/24011RMfg Jul 2025 · Exp Jun 2029 | Palam Pharma Pvt. LtdGujarat | IdentificationTest- Found to be Negative. Assay of Paracetamol IP-NilAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| Diclofenac Sodium and Paracetamol Tablets?. (DICLOZEG-P) | Batch TSF-B5792Mfg Oct 2023 · Exp Sep 2025 | Spen Formulations Pvt. Ltd | The Product is official in I.P 2022 but the same is not mentioned anywhere on the label.Labelling | State Drugs Laboratory, PunjabState lab |
| Diclofenac Sodium Tablets I.P.(Dicloax Plus) | Batch CDTP-265Mfg Sep 2024 · Exp Aug 2026 | Candor Biotech LtdPunjab | The sample does not conform to the IP with respect Assay of Diclofenac Sodium (NIL) and Found Aceclofenac (57.41 mg/Tab)Assay | DTL,Jaipur (State Lab)State lab |
| Dexamethasone Sodium Phosphate Injection IP (Dexona) | Batch N400726Mfg Jun 2024 · Exp Nov 2025 | Zydus Healthcare LimitedGujarat | Particulate matter, Assay of Dexamethasone Phosphate and DescriptionAssay | CDL, KolkataCDSCO lab |
| Depcof cough syrup | Batch L-2306077Mfg Jun 2023 · Exp May 2025 | Gopal life sciencesHimachal Pradesh | Assay of Phenylephrine Hydrochloride.Assay | DTL Baddi Distt Solan HPState lab |
| Dapagliflozin Tablets IP (DAPAWOHN) | Batch HT2406181Mfg Jun 2024 · Exp May 2026 | Helax Health Care Pvt. LtdUttarakhand | Assay and Uniformity of Content of DapagliflozinAssay | DTL Baddi Distt Solan HPState lab |
| Dapagliflozin Tablets IP (DAPAWOHN) | Batch HT2406181Mfg Jun 2024 · Exp May 2026 | Helax Health Care Pvt. LtdUttarakhand | Assay and Uniformity of Content of DapagliflozinAssay | DTL Baddi Distt Solan HPState lab |
| Compound Sodium Lactate Injection IP (Ringer-Lactate Solution for Injection) | Batch KI124110Mfg Dec 2024 · Exp Nov 2027 | Ultra Laboratories Pvt. LtdKarnataka | Test for SterilitySterility | KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer Lactate Solution for injectionI.P) RL | Batch 1247988Mfg Nov 2024 · Exp Oct 2027 | Otsuka Pharmaceutical India Private LimitedGujarat | Test for SterilitySterility | KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer's Lactate Solution Injection I.P)RL | Batch 13-4536Mfg Nov 2024 · Exp Oct 2027 | Ltd | Test for SterilitySterility | KarnatakaState lab |
| Codeine Phosphate, Chlorpheniramine Maleate and Sodium Citrate Cough Linctus (WYKAREX-CD Cough Linctus) | Batch AL-5770Mfg Nov 2023 · Exp Oct 2025 | Acron PharmaceuticalsGujarat | The Content of Codeine Phosphate in the sample less (i.e 32.50% of the labelled amount)Labelling | B.D. Marewad, FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Clopidogrel and Aspirin Tablets IP (AclizacAS 75) | Batch 2411039Mfg Nov 2024 · Exp Oct 2026 | Sanctus Global Formulations Limited | The sample does not conform to the IP with respect to Assay of Aspirin & Free Salicylic AcidAssay | DTL,Jaipur (StateState lab |
| Clopidogrel & Aspirin Tablets (75 mg/ 75 mg) | Batch GT241288Mfg Jul 2024 · Exp Jun 2026 | Theon Pharmaceuticals LtdHimachal Pradesh | DescriptionDescription | CDTL-MumbaiCDSCO lab |
| Ciprofloxacin Injection IP (0.2%w/v) (Ciprox) | Batch 2250946Mfg Feb 2025 · Exp Jan 2028 | Otsuka Pharmaceutical India Private LimitedGujarat | Particulate contamination.Particulate matter | CDL, KolkataCDSCO lab |
| Ciprofloxacin Hydrochloride Tablets IP 500mg (Cipro-500 Tablets | Batch COP24001Mfg Mar 2024 · Exp Feb 2026 | Danish Healthcare (P) Ltd. 76/27-28 | The sample does not comply with I.P requirement for DissolutionDissolution | N.S. Bhalerao, Nanded, FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Cefixime and Lactic Acid Bacillus Dispersible Tablets (Micoceff-LB 200 Tablets) | Batch CFL2411001Mfg Nov 2024 · Exp Oct 2026 | Maxcel Life CareMaharashtra | Identification and Assay of Cefixime Trihydate and Lactic Acid BacillusAssay | RDTL, ChandigarhCDSCO lab |
| Cefixime Tablets IP 200 mg | Batch B240875Mfg Jun 2024 · Exp May 2026 | Bochem Healthcare Pvt. Ltd. 83 | Test of WaterWater content | CDL, KolkataCDSCO lab |
| Cefixime 100 mg/5ml Powder for oral Suspension (Sunderin) | Batch MSSB24005Mfg Nov 2024 · Exp Nov 2026 | Nector Lifesciences Limited Unit-VIHimachal Pradesh | The sample does not conforms to Patent & Proprietary in repect to the Assay of Anhydrous Cefixime.Assay | DTL Baddi Distt Solan HPState lab |
| Cefixime &Ofloxacin Tablets (CEFXEN-O) | Batch VT240794Mfg Jul 2024 · Exp Jun 2026 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim with respect to assay of CefiximeAssay | DTL,Jaipur (State Lab)State lab |
| Calcium and Vitamin D3 Tablets IP(Tricum-XT) | Batch 1240247Mfg Feb 2024 · Exp Jul 2025 | Corona Remedies Pvt. LtdHimachal Pradesh | The Content of Vitamin D3 in the sample is less (i.e. 34.85% of the labelled amount) than the IP limitsLabelling | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Calcium and Vitamin D3 Tablets (Elprocal) | Batch NBT-230543Mfg Jan 2024 · Exp Dec 2025 | Soft Touch Pharmaceuticals India LtdHimachal Pradesh | Sample does not conform to IP specification for Calcium and Vitamin D3 Tablets with respect to the identification and content of Vitamin D3Identification | Drugs Testing Laboratory, Madurai-19State lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500) | Batch GTL1317Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500) | Batch GTL1295Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500) | Batch GTL1316Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL, KolkataCDSCO lab |
| Buprenorphine Injection I.P. (Talgesic Injection) | Batch BUP324002Mfg Jun 2024 · Exp May 2026 | Indus Pharma Pvt. LtdRajasthan | Spurious Identification and Assay of Buprenorphine Hydrochloride, Particulate matter and DescriptionAssay | CDL, KolkataCDSCO lab |
| Buprenorphin Injection I.P. (Noophin Injection) | Batch LM18898Mfg Nov 2022 · Exp Oct 2028 | Cooper Pharma LtdUttarakhand | Related Substances, Particulate matter, Sterility, Assay of Buprenorphine Hydrochloride eq. to Buprenorphine and DescriptionAssay | CDL, KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP 4 ml | Batch 17B24005Mfg Sep 2024 · Exp Aug 2026 | Radiant Parenterals LtdGujarat | pH, Bacterial Endotoxins Test, Particulate Matter in Injections and DescriptionDescription | CDL, KolkataCDSCO lab |
| Bromhexine Hcl Tabs. IP 8mg (Bronco) | Batch BRO-2401Mfg Jun 2024 · Exp May 2027 | Medibest Pharma Pvt. Ltd. N-31 | (1) The label of the received sample Bromhexine Hcl Tabs. IP 8mg (BRONCO), mentions the proper name of the drug whose font size is smaller than the brand name whereas the proper name of the drug should be at least two font size larger than the brand name as prescribed under Rule 96 (1), i (A) of the Drugs and Cosmetics Rules. (2) The name of the received sample mentions as Bromhexine HCL Tabs. IP 8mg, however Bromhexine HCL Tabs IP is an official monograph hence should be labelled as Bromhexine HCL Tabs IPLabelling | State lab , PuducherryState lab |
| Boldenone Undecylenate Injection 400mg/ml (VEBOLDEX 400) | Batch TST2301Mfg ? · Exp Apr 2027 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Betamethasone Valerate Ointment IP 0.1% w/w | Batch B73Mfg Aug 2024 · Exp Jul 2026 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | Drugs Testing Laboratory, Chennai-06State lab |
| Betamethasone Sodium Phosphate Injection IP (Betagin 1 ml) | Batch P24L107Mfg Aug 2024 · Exp Jul 2026 | Paksons Pharmaceuticals Private LimitedHaryana | Particulate matter, Assay of Betamethasone Sodium Phosphate and DescriptionAssay | CDL, KolkataCDSCO lab |
| Betahistine Dihydrochloride Tablet I.P (CGHEST-8) | Batch CT24250284AMfg May 2024 · Exp Apr 2026 | CMG Biotech Pvt. Ltd | DescriptionDescription | CDTL- IndoreCDSCO lab |
| Bacillus clausii Bakteriya shtammining polireist Suspension, Bacillus clausii Bakteriya shtammining polirezistent 2mlrd. Tirik bakteriyalar/5ml | Batch PSB-B00125Mfg Jan 2025 · Exp Dec 2026 | Prosafe Biologicals LLPTelangana | Total viable count found Less than 2 billion spores/5mlOther | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Azithromycin Tablets IP 500mg (Ronnin 500 Tablets) | Batch PPTC082Mfg Nov 2023 · Exp Oct 2026 | Pratima PharmaceuticalsMaharashtra | 1. The sample does gives identification for the presence of Azithromycin 2. Additional identification:-The sample gives identification for the presence of Paracetamol.3. Found Content of Paracetamol in the sample is 147.24mg/TabIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Azithromycin Tablets IP 500 mg | Batch DL-52Mfg Oct 2024 · Exp Sep 2026 | DUTCH FormulationsHimachal Pradesh | Dissolution, Uniformity of weight and Assay of Azithromycin Dihydrate calculated as AzithromycinAssay | RDTL, ChandigarhCDSCO lab |
| Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) | Batch Not mentionedMfg ? · Exp ? | Paradox PharmaceuticalsHimachal Pradesh | Identification, Dissolution and Assay of Azithromycin Dihydrate Calculated as Anhydrous AzithromycinAssay | RDTL, ChandigarhCDSCO lab |
| Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) | Batch AZR2411010Mfg Jan 2025 · Exp Dec 2026 | Paradox PharmaceuticalsHimachal Pradesh | Identification, Dissolution and the Assay of AzithromycinAssay | RDTL, ChandigarhCDSCO lab |
| Azithromycin Oral Suspension | Batch A004Mfg Dec 2023 · Exp Nov 2025 | Smith & Kenner Pharmaceuticals Pvt.LtdTelangana | The label of the drug should be mentioned as Azithromycin Oral suspension IP. But the letters IP is not mentioned on the labelLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Axid 200 (Sucralfate Oral Suspension) | Batch 624-470Mfg Jun 2024 · Exp May 2026 | Zee Laboratories LtdHimachal Pradesh | Sample does not conform with respect to General requirements for liquid dosage formOther | Drugs Testing Laboratory, Chennai-06State lab |
| Atorvastatin Tablets IP 10mg (Atosar-10) | Batch SBT-813Mfg Mar 2024 · Exp Feb 2026 | Sarthak Biotech Pvt. Ltd | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Atorvastatin Tablets IP 10mg | Batch CT240237AMfg Jul 2024 · Exp Jun 2025 | Candour PharmaceuticalsHimachal Pradesh | Sample does not conform to IP specification for Atorvastatin Tablets with respect to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxycillin& Potassium Clavulanate Tablets I.P. 625 mg (TIMOX ? CV 625) | Batch AXP5F5007Mfg Jan 2025 · Exp Dec 2026 | Sucantis Bio Tech Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for Dissolution of AmoxycillinDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin& Potassium Clavulanate Tablets I.P (AMOXMED ? CV 625 Tablets) | Batch ABT24071Mfg May 2024 · Exp Oct 2025 | Alexa PharmaceuticalsHimachal Pradesh | The sample does not conform to standard quality in respect of the test for Dissolution & AssayAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin& Potassium Clavulanate Tablets I.P (AGECLAV ? 375 Tablets) | Batch JMT-240801AMfg Aug 2024 · Exp Jan 2026 | JMM Formulation Pvt. LtdHimachal Pradesh | The Sample does not conform to Standard Quality in respect of the test for Dissolution of AmoxycillinDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin with Potassium Clavulanate Tablets I.P. (CLAIM ? CV 625) | Batch CT/24/747Mfg Oct 2024 · Exp Mar 2026 | Ciphem PharmaGujarat | The Sample does not conform to standard in respect of the test for Uniformity of weight, Dissolution & AssayAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin and Potassium Clavulanate with Lactic Acid Bacillus Tablets (Polo-625 LB Tablets) | Batch PL2406001Mfg Oct 2024 · Exp Nov 2026 | Paradox PharmaceuticalsHimachal Pradesh | Identification and Assay of Amoxycillin Trihydrate, Potassium Clavulanate and Lactic Acid BacillusAssay | RDTL, ChandigarhCDSCO lab |
| Amoxycillin and Potassium Clavulanate Tablets IP (Rumentin-625 Tablets) | Batch RUM2411002Mfg Nov 2024 · Exp Oct 2026 | Rextuse PharmaceuticalsUttarakhand | Identification and Assay of Amoxycillin Trihydrate and Potassium Clavulanate and Dissolution of Amoxycillin Trihydrate and Potassium ClavulanateAssay | RDTL, ChandigarhCDSCO lab |
| Amoxycillin and Potassium Clavulanate Oral Suspension RIGHTCLAV 228.5 Dry Syrup | Batch ACAG24001EMfg Apr 2024 · Exp Sep 2025 | J.M. LaboratoriesHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with respect to pH and the content of Clavulanic Acid in Potassium Clavulanate dilutedpH | Drugs Testing Laboratory, Madurai-19State lab |
| Amoxycillin Trihydrate Capsules I.P. (Zymox-500 (Yellow)) | Batch ZYMC-2407Mfg Apr 2024 · Exp Apr 2026 | Laborate Pharmaceuticals India LtdHaryana | Assay/ content of AmoxycillinAssay | CDTL-MumbaiCDSCO lab |
| Amoxycillin Capsules IP 500mg (Moxgo-500) | Batch MOXG-2404001Mfg Jul 2024 · Exp Jun 2026 | RMIS PharmaceuticalsChhattisgarh | The sample does not conform to the IP as it does not contain Amoxycillin (NIL)Other | DTL, Jaipur (State Lab)State lab |
| Amoxycillin Capsules IP 250mg (Amoxi 250) | Batch MT14AC08Mfg Aug 2023 · Exp Jul 2025 | Malik Lifesciences Pvt. LtdUttarakhand | Does not comply with respect to test for AssayAssay | State lab , PuducherryState lab |
| Amoxycillin & Potassium Clavulanate for Oral Suspension, | Batch UPS-245CMfg Jan 2024 · Exp Jun 2025 | Ultra Drugs Pvt. LtdHimachal Pradesh | The drug product Amoxcycillin and potassium Clavulanate for Oral suspension is official in the current edition of IP 2022. But the designation in conjiction with the product title Amoxycillin and Potassium Clavulanate for Oral suspension IP is not mentioned on the product LabelLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Amlodipine Besylate Tablets I.P. 2.5 mg (AMLODOSE ? 2.5) | Batch SPT240321Mfg Feb 2024 · Exp Jan 2026 | Salus PharmaceuticalsHimachal Pradesh | The Sample does not conform to standard in respect of the test for Assay & Uniformity of ContentAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amikacin Sulphate Injection IP 500mg (Amikablast 500 Injection) | Batch W373Mfg Jul 2023 · Exp Jun 2025 | Macin Remedies India Ltd. B-21 | The content of Amikacin in the sample is more (i.e 183.99% of the lablled amount) than the I.P limitsOther | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Ambroxol Hydrochloride, Terbutaline sulphate, Guaiphenesin & Menthol syrup (TEXORIL-AM Syrups), | Batch MXS-9081Mfg Nov 2023 · Exp Oct 2025 | Maxtra LaboratoriestifindustrialparkTelangana | The drug failed to indicate the common name of the color contained in the drug on the label of the product, as required by Rule 127(2) of the Drugs Rules, 1945. It was mentioned on the label as Approved Colours used.Labelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Vitamin B6 &Vitamin D3 Tablets) | Batch AT-052410Mfg May 2024 · Exp Apr 2026 | East African (India) OverseasUttarakhand | Test for Disintegration onlyDisintegration | KarnatakaState lab |
| Alcinac-SR Tablets (Aceclofenac Sustained-release Tablets) | Batch 9244001Mfg May 2024 · Exp Apr 2026 | Leeford Healthcare LtdHimachal Pradesh | Dissolution of AceclofenacDissolution | Drugs Testing Laboratory, BaddiState lab |
| Albendazole tablets IP 400mg | Batch T24/006AMfg Dec 2024 · Exp Nov 2026 | SamkemMadhya Pradesh | Sample does not meet the Specifications wrt. Dissolution Test as per IPDissolution | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Albendazole tablets IP 400mg | Batch T24/021AMfg Dec 2024 · Exp Nov 2026 | SamkemMadhya Pradesh | The sample does not comply with respect to Dissolution Test as per IP 2022Dissolution | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablets IP 400 mg (ALBISTI ? 400) | Batch PI28AH05Mfg Jul 2023 · Exp Dec 2025 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The Sample does not conform to standard in respect of the test for DissolutionDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Albendazole Tablets I.P. 400 mg (B-ZOLE 400 mg) | Batch T50120AMfg Feb 2025 · Exp Jan 2027 | Samson Laboratories Pvt. LtdHimachal Pradesh | The sample does not conform to standard quality in respect of the test for DissolutionDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Albendazole Oral Suspension IP (Vet.) | Batch SLG24095Mfg Mar 2024 · Exp Feb 2026 | Safecon Lifesciences Pvt. Ltd | The sample does not conform to the IP with respect to Assay of AlbendazoleAssay | DTL, Jaipur (State Lab)State lab |
| Albendazole Chewable Tablets IP (Alsia-400 Tab | Batch SPD-618Mfg Oct 2024 · Exp Sep 2026 | Sia Pharma Pvt. LtdHaryana | The sample does not comply with I.P requirement for Dissolution TestDissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Advanced Pakiza Unani's Golden Knight Cream | Batch PUNC02Mfg Apr 2024 · Exp Mar 2027 | Advanced Pakiza Unani LLP | 1. The sample gives identification for the presence of Tadalafil.. 2. Found Content of Tadalafil in the sample is 0.17mg/gmIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Advanced Pakiza Unani's Golden Knight Capsules | Batch GKC002AMfg Nov 2023 · Exp Oct 2026 | Advanced Pakiza Unani LLP | 1. The sample gives identification for the presence of Sildenafil Citrate and Tadalafil. 2. Found Content of Sildenafil in the sample is 9.65mg/Cap 3. Found Content of Tadalafil in the sample is 12.77mg/CapIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Advanced Pakiza Unani's Golden Knight 125g | Batch PUN45Mfg Nov 2024 · Exp Oct 2027 | Advanced Pakiza Unani LLPMaharashtra | 1. The sample gives identification for the presence of Sildenafil Citrate. 2. Found Content of Sildenafil in the sample is 33.72 mg/10gmIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Acidom-DSR Capusles | Batch 2560301CMfg Jul 2023 · Exp Jun 2025 | LifecarePuducherry | The content of Rabeprozole in the sample is less (i.e 31.85% of the lablled amount) than permissible limitsOther | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Acelofenac & Paracetamol Tablets (ACELOZAL-P) | Batch YLT25005Mfg Jan 2025 · Exp Dec 2026 | YL Pharma BaddiHimachal Pradesh | The sample does not conforms to Patent & Proprietary in repect to the Assay of Aceclofenac.Assay | DTL Baddi Distt Solan HPState lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets (ACIJAN-SP Tablets) | Batch AF-23T683Mfg Oct 2023 · Exp Sep 2025 | Affine Formulations Ltd.1947/3Himachal Pradesh | The Content of Serratiopeptidase in the sample is less(i.e 41.54% of lebelled amount)Other | V.P. Mahajan, Jalna. FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Aceclofenac Tablets I.P 100 mg | Batch T4167Mfg May 2024 · Exp Apr 2026 | Zest PharamaMadhya Pradesh | DescriptionDescription | CDTL- IndoreCDSCO lab |
| Aceclofenac Paracetamol & Serratiopeptidase Tablets. (Aceclofen-SP) | Batch PBT-2024101Mfg May 2024 · Exp Apr 2026 | Presun Biotech | The contents of Serratiopeptidase found to be 8.06mg per tablet (80.6%) against labeled claim of 10.0mg per tablet.Labelling | State Drugs Laboratory, PunjabState lab |
| Aceclofenac & Paracetamol Tablets (Aceclon-P) | Batch NTT250578Mfg Feb 2025 · Exp Jan 2028 | Nanoceut Therapeutics Pvt. LtdPuducherry | The sample received is labelled as Aceclofenac And Paracetamol Tablets (Aceclon-P), however Aceclofenac And Paracetamol Tablets is an official IP monograph (IP Addendum 2024) hence should be labelled as Aceclofenac And Paracetamol Tablets IPLabelling | State lab , PuducherryState lab |
| Aceclofenac & Paracetamol Tablets (A-Sid Tablets) | Batch HT-2401253Mfg Dec 2024 · Exp Nov 2026 | Helax Health Care Pvt. LtdUttarakhand | (1)The sample received is labelled as Aceclofenac & Paracetamol Tablets, however Aceclofenac & Paracetamol Tablets is an official IP monograph (Addendum 2024) hence should be labelled as Aceclofenac & Paracetamol Tablets IP. (2)For the received sample, Discolouration was observed. (3) Does not comply with respect to test for Uniformity of weight and Assay for Aceclofenac and ParacetamolAssay | State lab , PuducherryState lab |
| Aceclofenac & Paracetamol Tablets (Elzefen-P) | Batch PC24021Mfg Mar 2024 · Exp Feb 2026 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | Assay of AceclofenacAssay | CDL, KolkataCDSCO lab |
| ALBENDAZOLE TABLETS I.P. | Batch PGT24407Mfg Jul 2024 · Exp Jun 2027 | Affy ParenteralsHimachal Pradesh | Dissolution of AlbendazoleDissolution | RDTL, ChandigarhCDSCO lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (188 rows). Revised CDSCO lists are diffed on each monthly rebuild.